ArticleJournal of substance use2026
Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder.
Article in Journal of substance use, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Objective: To assess the impacts of personal or family COVID-19 infection on health-related quality of life (HRQOL) among patients with opioid use disorder (OUD). Methods: From July 2021-July 2022, adults recruited from an OUD treatment clinic self-reported personal or family experiences of COVID-19 infection including exposures, quarantine, symptoms, positive tests, treatment, and severe illness. (one point for each positive response). HRQOL outcomes included (1) single-item general health (range: poor to excellent), and (2) HRQOL dimensions (problems with mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Logistic regression quantified associations between COVID-19 impact scores and odds of (1) poorer general health and (2) each HRQOL dimension. Results: Among 149 participants, the average age was 49, 62.2% were white/non-Hispanic, 57% were male and median COVID-19 impact score was 4(IQR: 2-8). Many experienced problems with mobility (41.9%), usual activities (41.9%), and anxiety/depression (73.0%). Higher COVID-19 scores were associated with increased odds of problems with mobility, usual activities, and anxiety/depression (aOR=1.10, 95%CI:1.02-1.17; aOR=1.07 95%CI:1.00-1.14; aOR=1.21, 95%CI:1.09-1.34, respectively). Conclusions: Increased COVID-19 infection impacts were associated with specific HRQOL problems with mobility, usual activities and anxiety/depression. Resources are needed to protect HRQOL for this at-risk population during times of stress and healthcare disruption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.